We used a BC specific driver, slow border cell GAL4 (slbo-GAL4) [46, 47] to drive expression of a UAS-GFP reporter and a UAS-RNAi transgene targeted against the gene of interest. The gene discussed is LGALS4; the disease is breast cancer.